Octamethylcyclotetra-siloxane (D4); Final Scope of the Risk Evaluation To Be Conducted Under the Toxic Substances Control Act (TSCA); Notice of Availability, 12696-12697 [2022-04676]
Download as PDF
<![CDATA[
12696
Federal Register / Vol. 87, No. 44 / Monday, March 7, 2022 / Notices
Federal Register. 82 FR 7562, January
18, 2017 (FRL–9957–75).
7. EPA. Final Rule; Procedures for Chemical
Risk Evaluation Under the Amended
Toxic Substances Control Act. Federal
Register. 82 FR 33726, July 20, 2017
(FRL–9964–38).
8. EPA. Summary of External Peer Review
and Public Comments and Disposition
for C.I. Pigment Violet 29 (PV29)
(Anthra[2,1,9-def:6,5,10d′e′f′]diisoquinoline-1,3,8,10(2H,9H)tetrone). January 2021. https://
www.regulations.gov/document/EPAHQ-OPPT-2018-0604-0126.
Authority: 15 U.S.C. 2601 et seq.
Michael S. Regan,
Administrator.
[FR Doc. 2022–04672 Filed 3–4–22; 8:45 am]
BILLING CODE 6560–50–P
ENVIRONMENTAL PROTECTION
AGENCY
I. General Information
[EPA–HQ–OPPT–2018–0443; FRL–8850–02–
OCSPP]
Octamethylcyclotetra-siloxane (D4);
Final Scope of the Risk Evaluation To
Be Conducted Under the Toxic
Substances Control Act (TSCA); Notice
of Availability
Environmental Protection
Agency (EPA).
ACTION: Notice.
AGENCY:
In accordance with the Toxic
Substances Control Act (TSCA) and
implementing regulations, EPA is
announcing the availability of the final
scope of the risk evaluation to be
conducted for octamethylcyclotetrasiloxane (D4) (Cyclotetrasiloxane,
2,2,4,4,6,6,8,8-octamethyl-; Chemical
Abstracts Service Registry Number
(CASRN) 556–67–2), a chemical
substance for which EPA received a
manufacturer request for risk
evaluation. The scope document
includes the conditions of use, hazards,
exposures, and the potentially exposed
or susceptible subpopulations that EPA
plans to consider in conducting the risk
evaluation for this chemical substance.
ADDRESSES: The docket, identified by
docket identification (ID) number EPA–
HQ–OPPT–2018–0443, is available
online at https://www.regulations.gov or
in-person at the Office of Pollution
Prevention and Toxics Docket (OPPT
Docket), Environmental Protection
Agency Docket Center (EPA/DC), West
William Jefferson Clinton Bldg., Rm.
3334, 1301 Constitution Ave. NW,
Washington, DC.
Due to the public health concerns
related to COVID–19, the EPA Docket
Center (EPA/DC) and Reading Room is
khammond on DSKJM1Z7X2PROD with NOTICES
SUMMARY:
VerDate Sep<11>2014
17:50 Mar 04, 2022
Jkt 256001
open to visitors by appointment only.
For the latest status information on
EPA/DC services and docket access,
visit https://www.epa.gov/dockets.
FOR FURTHER INFORMATION CONTACT:
For technical information contact:
Bethany Masten, Existing Chemical Risk
Management Division, Office of
Pollution Prevention and Toxics,
Environmental Protection Agency
(Mailcode 7404T), 1200 Pennsylvania
Ave. NW, Washington, DC 20460–0001;
telephone number: (202) 564–8803;
email address: masten.bethany@
epa.gov.
For general information contact: The
TSCA-Hotline, ABVI-Goodwill, 422
South Clinton Ave., Rochester, NY
14620; telephone number: (202) 554–
1404; email address: TSCA-Hotline@
epa.gov.
SUPPLEMENTARY INFORMATION:
A. Does this action apply to me?
This action is directed to the public
in general and may be of interest to
entities that manufacture (including
import) a chemical substance regulated
under TSCA (e.g., entities identified
under North American Industrial
Classification System (NAICS) codes
325 and 324110). The action may also
be of interest to chemical processors,
distributors in commerce, and users;
non-governmental organizations in the
environmental and public health
sectors; state and local government
agencies; and members of the public.
Since other entities may also be
interested, the Agency has not
attempted to describe all the specific
entities and corresponding NAICS codes
for entities that may be interested in or
affected by this action.
B. What is the Agency’s authority for
taking this action?
The final scope document is issued
pursuant to TSCA section 6(b)(4)(D) and
TSCA implementing regulations at 40
CFR 702.41(c)(8).
C. What action is the Agency taking?
EPA is publishing the final scope of
the risk evaluation for D4 under TSCA.
Through the risk evaluation process,
EPA will determine whether the
chemical substance presents an
unreasonable risk of injury to health or
the environment under the conditions of
use, in accordance with TSCA section
6(b)(4).
II. Background
TSCA allows chemical manufacturers
to request an EPA-conducted risk
evaluation of a chemical substance
PO 00000
Frm 00041
Fmt 4703
Sfmt 4703
under 40 CFR 702.37. On March 19,
2020, EPA received a manufacturer
request for a risk evaluation of D4 (Ref.
1). On June 17, 2020, EPA opened a 45day public comment period to gather
information relevant to the requested
risk evaluation. EPA granted the request
on October 6, 2020, and subsequently
initiated the scoping process for the risk
evaluation for this chemical substance.
Pursuant to 40 CFR 702.41(c)(7), EPA
announced the availability of and
sought public comment on the draft
scope document for the risk evaluation
to be conducted for D4 under TSCA (86
FR 50347, September 8, 2021) (FRL–
8850–01–OCSPP) (Ref. 2).
The purpose of risk evaluation is to
determine whether a chemical
substance, or category of chemical
substances, presents an unreasonable
risk of injury to health or the
environment, under the conditions of
use, including an unreasonable risk to a
relevant potentially exposed or
susceptible subpopulation (15 U.S.C.
2605(b)(4)(A)). As part of this process,
EPA must evaluate both hazards and
exposures for the conditions of use;
describe whether aggregate or sentinel
exposures were considered and the
basis for consideration; not consider
costs or other nonrisk factors; take into
account, where relevant, likely duration,
intensity, frequency, and number of
exposures and describe the weight of
the scientific evidence for hazards and
exposures (15 U.S.C. 2605(b)(4)(F)). This
process will culminate in a
determination of whether the chemical
substance presents an unreasonable risk
of injury to health or the environment
under the conditions of use (15 U.S.C.
2605(b)(4)(A); 40 CFR 702.47).
III. Information and Comments
Received on the Draft Scope
In the Federal Register of September
8, 2021 (Ref. 2), EPA announced the
availability of the draft scope document
for the risk evaluation to be conducted
for D4 under TSCA and invited public
comments on EPA’s draft scope
document, including additional data or
information relevant to the chemical
substance or that otherwise could be
useful to the Agency in finalizing the
scope of the risk evaluation. To the
extent that comments provided
information on conditions of use, as
well as other elements of the draft scope
document, those comments and other
submitted information (e.g., relevant
studies, assessments, information on
degradation products, and information
on conditions of use) were used to
inform revisions to the draft scope
document and may be considered in
E:\FR\FM\07MRN1.SGM
07MRN1
Federal Register / Vol. 87, No. 44 / Monday, March 7, 2022 / Notices
subsequent phases of the risk evaluation
process.
EPA received six unique submissions
for D4, including comments from
potentially affected businesses or trade
associations, environmental and public
health advocacy groups, and one
member of the general public.
Comments addressed the overall
approach to the risk evaluation process
(e.g., collection, consideration, and
systematic review of relevant
information), the specific elements of
the scope document (e.g., hazard,
exposure, and potentially exposed or
susceptible subpopulations),
information specific to the chemical
substance (e.g., relevant studies,
assessments, degradation products, and
conditions of use), and topics beyond
the draft scope document phase of the
process (e.g., risk management). EPA
considered those comments, as
applicable and appropriate, in
developing the final scope document.
Concurrently with the publication of the
final scope document, EPA is
publishing a response to comments
document that contains a
comprehensive summary of and
response to public comments received
on the D4 draft scope document. The
comprehensive response to comments
document is available in the docket
EPA–HQ–OPPT–2018–0443 (Ref. 3).
IV. References
khammond on DSKJM1Z7X2PROD with NOTICES
The following is a listing of the
documents that are specifically
referenced in this Federal Register
notice. The docket for this action
includes these documents and other
information considered by EPA,
including documents that are referenced
within the documents that are included
in the docket. For assistance in locating
these referenced documents, please
consult the technical person listed
under FOR FURTHER INFORMATION
CONTACT.
1. EPA. Octamethylcyclotetra-Siloxane (D4);
Manufacturer Request for Risk
Evaluation Under the Toxic Substances
Control Act (TSCA); Notice of
Availability and Request for Comments.
Federal Register. (85 FR 36586, June 17,
2020) (FRL–10010–49).
2. EPA. Octamethylcyclotetra-Siloxane (D4);
Draft Scope of the Risk Evaluation to be
Conducted Under the Toxic Substances
Control Act (TSCA); Notice of
Availability and Request for Comments.
Federal Register. (86 FR 50347,
September 8, 2021) (FRL–8850–01–
OCSPP).
3. EPA. EPA Response to Public Comments
Received on the Draft Scope of the Risk
Evaluation for Under the Toxic
Substances Control Act (TSCA) for
Octamethylcyclotetra-siloxane
VerDate Sep<11>2014
17:50 Mar 04, 2022
Jkt 256001
(Cyclotetrasiloxane, 2,2,4,4,6,6,8,8octamethyl-) (D4) CASRN 556–67–2
(March 2022).
Authority: 15 U.S.C. 2601 et seq.
Michael S. Regan,
Administrator.
[FR Doc. 2022–04676 Filed 3–4–22; 8:45 am]
BILLING CODE 6560–50–P
FEDERAL COMMUNICATIONS
COMMISSION
[MB Docket No. 22–76; FCC DA 22–187;
FR ID 74348]
Application of The Marion Education
Exchange for Renewal of License for
Station WWGH–LP, Marion, Ohio
Federal Communications
Commission.
ACTION: Notice.
AGENCY:
This Hearing Designation
Order, Notice of Opportunity for
Hearing, and Notice of Apparent
Liability for Forfeiture (Order)
commences a hearing to determine
whether The Marion Education
Exchange (MEE) has committed
violations of the Communications Act of
1934, as amended (Act) and/or the rules
and regulations (Rules) of the Federal
Communications Commission
(Commission), and, as a consequence,
whether MEE’s application (Renewal
Application) to renew the license of low
power FM radio station WWGH–LP,
Marion, Ohio (Station) should be
granted or denied pursuant to section
309(k) of the Act, and whether a
forfeiture should be imposed against
MEE.
DATES: Persons desiring to participate as
parties in the hearing shall file a
petition for leave to intervene not later
than April 6, 2022.
ADDRESSES: File documents with the
Office of the Secretary, Federal
Communications Commission, 45 L
Street NE, Washington, DC 20554, with
a copy mailed to each party to the
proceeding. Each document that is filed
in this proceeding must display on the
front page the docket number of this
hearing, ‘‘MB Docket No. 22–76.’’
FOR FURTHER INFORMATION CONTACT:
Albert Shuldiner, Media Bureau, (202)
418–2721.
SUPPLEMENTARY INFORMATION: This is a
summary of the Hearing Designation
Order, Notice of Opportunity for
Hearing, and Notice of Apparent
Liability for Forfeiture (Order), MB
Docket No. 22–76, FCC DA 22–187,
adopted and released February 23, 2022.
The full text of the Order is available
SUMMARY:
PO 00000
Frm 00042
Fmt 4703
Sfmt 4703
12697
online by using the search function for
MB Docket No. 22–76 on the
Commission’s ECFS web page at https://
apps.fcc.gov/ecfs/.
Summary of the Order
1. MEE was registered with the State
of Ohio as a non-profit corporation on
May 2, 2019, with Shawn Craft as the
registered agent. On May 9, 2019, MEE
and Marion Midget Football (MMF)—
the Station’s former licensee—filed an
application for Commission consent to
the pro forma assignment of the
Station’s license from MMF to MEE
(Assignment Application). Therein,
MEE indicated that ‘‘[t]here are no
changes in the board members, only the
name of the licensee.’’ MEE listed Patti
Worcester (Worcester), Martha Maniaci
(Maniaci), Mary Ann Stolarczyk
(Stolarczyk), Betty Compton (Compton),
and Marge Hazelett (Hazelett) as its
board members, and indicated each had
20 percent voting rights. We granted the
unopposed Assignment Application on
May 21, 2019. In the course of this
license renewal proceeding, we have
learned that Compton died on
November 7, 2016, more than two years
before MEE filed the Assignment
Application that listed her as one of five
existing and continuing members of
MEE’s board.
2. On May 28, 2019, MEE filed a pro
forma transfer of control application
(Transfer Application). MEE reported
that ‘‘Worcester has decided to retire
and voluntarily transfers her position to
Shawn Craft.’’ We granted the
unopposed Transfer Application on July
11, 2019.
3. On June 6, 2020, MEE filed the
Renewal Application. Spencer Phelps
(Phelps) then filed an Informal
Objection. Phelps alleged that MEE had
misrepresented its board composition in
the Assignment Application. Phelps
stated that the board members of MEE
were ‘‘completely different people’’ than
those MEE listed in the Assignment
Application, and argued that MEE’s
statement in that application that there
were ‘‘no changes in the board
members, only the name of the
licensee’’ was false. To support his
claim, Phelps submitted copies of
corporate materials that MEE had filed
with the State of Ohio. The corporate
materials did not list Worcester,
Maniaci, Stolarczyk, Compton, or
Hazelett, the names listed in the
Assignment Application. Instead, they
listed four different individuals: Shawn
Craft (Craft), Linda Sims (Sims), Glenn
Coble (Coble), and Terry Tackett
(Tackett).
4. MEE did not respond to the
Informal Objection. Accordingly, we
E:\FR\FM\07MRN1.SGM
07MRN1
]]>Agencies
[Federal Register Volume 87, Number 44 (Monday, March 7, 2022)]
[Notices]
[Pages 12696-12697]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-04676]
-----------------------------------------------------------------------
ENVIRONMENTAL PROTECTION AGENCY
[EPA-HQ-OPPT-2018-0443; FRL-8850-02-OCSPP]
Octamethylcyclotetra-siloxane (D4); Final Scope of the Risk
Evaluation To Be Conducted Under the Toxic Substances Control Act
(TSCA); Notice of Availability
AGENCY: Environmental Protection Agency (EPA).
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: In accordance with the Toxic Substances Control Act (TSCA) and
implementing regulations, EPA is announcing the availability of the
final scope of the risk evaluation to be conducted for
octamethylcyclotetra-siloxane (D4) (Cyclotetrasiloxane,
2,2,4,4,6,6,8,8-octamethyl-; Chemical Abstracts Service Registry Number
(CASRN) 556-67-2), a chemical substance for which EPA received a
manufacturer request for risk evaluation. The scope document includes
the conditions of use, hazards, exposures, and the potentially exposed
or susceptible subpopulations that EPA plans to consider in conducting
the risk evaluation for this chemical substance.
ADDRESSES: The docket, identified by docket identification (ID) number
EPA-HQ-OPPT-2018-0443, is available online at https://www.regulations.gov or in-person at the Office of Pollution Prevention
and Toxics Docket (OPPT Docket), Environmental Protection Agency Docket
Center (EPA/DC), West William Jefferson Clinton Bldg., Rm. 3334, 1301
Constitution Ave. NW, Washington, DC.
Due to the public health concerns related to COVID-19, the EPA
Docket Center (EPA/DC) and Reading Room is open to visitors by
appointment only. For the latest status information on EPA/DC services
and docket access, visit https://www.epa.gov/dockets.
FOR FURTHER INFORMATION CONTACT:
For technical information contact: Bethany Masten, Existing
Chemical Risk Management Division, Office of Pollution Prevention and
Toxics, Environmental Protection Agency (Mailcode 7404T), 1200
Pennsylvania Ave. NW, Washington, DC 20460-0001; telephone number:
(202) 564-8803; email address: [email protected].
For general information contact: The TSCA-Hotline, ABVI-Goodwill,
422 South Clinton Ave., Rochester, NY 14620; telephone number: (202)
554-1404; email address: [email protected].
SUPPLEMENTARY INFORMATION:
I. General Information
A. Does this action apply to me?
This action is directed to the public in general and may be of
interest to entities that manufacture (including import) a chemical
substance regulated under TSCA (e.g., entities identified under North
American Industrial Classification System (NAICS) codes 325 and
324110). The action may also be of interest to chemical processors,
distributors in commerce, and users; non-governmental organizations in
the environmental and public health sectors; state and local government
agencies; and members of the public. Since other entities may also be
interested, the Agency has not attempted to describe all the specific
entities and corresponding NAICS codes for entities that may be
interested in or affected by this action.
B. What is the Agency's authority for taking this action?
The final scope document is issued pursuant to TSCA section
6(b)(4)(D) and TSCA implementing regulations at 40 CFR 702.41(c)(8).
C. What action is the Agency taking?
EPA is publishing the final scope of the risk evaluation for D4
under TSCA. Through the risk evaluation process, EPA will determine
whether the chemical substance presents an unreasonable risk of injury
to health or the environment under the conditions of use, in accordance
with TSCA section 6(b)(4).
II. Background
TSCA allows chemical manufacturers to request an EPA-conducted risk
evaluation of a chemical substance under 40 CFR 702.37. On March 19,
2020, EPA received a manufacturer request for a risk evaluation of D4
(Ref. 1). On June 17, 2020, EPA opened a 45-day public comment period
to gather information relevant to the requested risk evaluation. EPA
granted the request on October 6, 2020, and subsequently initiated the
scoping process for the risk evaluation for this chemical substance.
Pursuant to 40 CFR 702.41(c)(7), EPA announced the availability of and
sought public comment on the draft scope document for the risk
evaluation to be conducted for D4 under TSCA (86 FR 50347, September 8,
2021) (FRL-8850-01-OCSPP) (Ref. 2).
The purpose of risk evaluation is to determine whether a chemical
substance, or category of chemical substances, presents an unreasonable
risk of injury to health or the environment, under the conditions of
use, including an unreasonable risk to a relevant potentially exposed
or susceptible subpopulation (15 U.S.C. 2605(b)(4)(A)). As part of this
process, EPA must evaluate both hazards and exposures for the
conditions of use; describe whether aggregate or sentinel exposures
were considered and the basis for consideration; not consider costs or
other nonrisk factors; take into account, where relevant, likely
duration, intensity, frequency, and number of exposures and describe
the weight of the scientific evidence for hazards and exposures (15
U.S.C. 2605(b)(4)(F)). This process will culminate in a determination
of whether the chemical substance presents an unreasonable risk of
injury to health or the environment under the conditions of use (15
U.S.C. 2605(b)(4)(A); 40 CFR 702.47).
III. Information and Comments Received on the Draft Scope
In the Federal Register of September 8, 2021 (Ref. 2), EPA
announced the availability of the draft scope document for the risk
evaluation to be conducted for D4 under TSCA and invited public
comments on EPA's draft scope document, including additional data or
information relevant to the chemical substance or that otherwise could
be useful to the Agency in finalizing the scope of the risk evaluation.
To the extent that comments provided information on conditions of use,
as well as other elements of the draft scope document, those comments
and other submitted information (e.g., relevant studies, assessments,
information on degradation products, and information on conditions of
use) were used to inform revisions to the draft scope document and may
be considered in
[[Page 12697]]
subsequent phases of the risk evaluation process.
EPA received six unique submissions for D4, including comments from
potentially affected businesses or trade associations, environmental
and public health advocacy groups, and one member of the general
public.
Comments addressed the overall approach to the risk evaluation
process (e.g., collection, consideration, and systematic review of
relevant information), the specific elements of the scope document
(e.g., hazard, exposure, and potentially exposed or susceptible
subpopulations), information specific to the chemical substance (e.g.,
relevant studies, assessments, degradation products, and conditions of
use), and topics beyond the draft scope document phase of the process
(e.g., risk management). EPA considered those comments, as applicable
and appropriate, in developing the final scope document. Concurrently
with the publication of the final scope document, EPA is publishing a
response to comments document that contains a comprehensive summary of
and response to public comments received on the D4 draft scope
document. The comprehensive response to comments document is available
in the docket EPA-HQ-OPPT-2018-0443 (Ref. 3).
IV. References
The following is a listing of the documents that are specifically
referenced in this Federal Register notice. The docket for this action
includes these documents and other information considered by EPA,
including documents that are referenced within the documents that are
included in the docket. For assistance in locating these referenced
documents, please consult the technical person listed under FOR FURTHER
INFORMATION CONTACT.
1. EPA. Octamethylcyclotetra-Siloxane (D4); Manufacturer Request for
Risk Evaluation Under the Toxic Substances Control Act (TSCA);
Notice of Availability and Request for Comments. Federal Register.
(85 FR 36586, June 17, 2020) (FRL-10010-49).
2. EPA. Octamethylcyclotetra-Siloxane (D4); Draft Scope of the Risk
Evaluation to be Conducted Under the Toxic Substances Control Act
(TSCA); Notice of Availability and Request for Comments. Federal
Register. (86 FR 50347, September 8, 2021) (FRL-8850-01-OCSPP).
3. EPA. EPA Response to Public Comments Received on the Draft Scope
of the Risk Evaluation for Under the Toxic Substances Control Act
(TSCA) for Octamethylcyclotetra-siloxane (Cyclotetrasiloxane,
2,2,4,4,6,6,8,8-octamethyl-) (D4) CASRN 556-67-2 (March 2022).
Authority: 15 U.S.C. 2601 et seq.
Michael S. Regan,
Administrator.
[FR Doc. 2022-04676 Filed 3-4-22; 8:45 am]
BILLING CODE 6560-50-P
